» Articles » PMID: 21744988

Interaction of Human Adipose Tissue-derived Mesenchymal Stromal Cells with Breast Cancer Cells

Overview
Journal Neoplasma
Specialty Oncology
Date 2011 Jul 13
PMID 21744988
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Human adipose tissue was shown to be a very attractive source of mesenchymal stromal cells that have a wide scale of potential applications in reconstructive plastic surgery and regenerative medicine. However, these cells were described to have profound effects on biological behaviour of tumour cells. The aim of this study was to analyze the influence of adipose tissue-derived human mesenchymal stromal cells (AT-MSC) on the proliferation of breast cancer cells. We have tested proliferation of three different human breast cancer cell lines under the influence of AT-MSC derived soluble factors as well as in the direct cocultures. These data were supplemented with the expression analysis of cytokines and their cognate receptors on the target cells. We have observed stimulation of proliferation in breast cancer cells MDA-MB-361, T47D and EGFP-MCF7. AT-MSC were found to secrete wide scale of cytokines, chemokines and growth factors, thus we concluded that this pro-proliferative effect was a result of their synergistic action. These data bring out a need to evaluate whether primary breast tumour derived human cells would respond to these type of stimuli in a similar manner in order to exclude any potential clinical risk related to the application of human mesenchymal stromal cells under the context of patient with history of breast cancer malignancy.

Citing Articles

Cell-cell interactions mediating primary and metastatic breast cancer dormancy.

Lenart N, Rao S Cancer Metastasis Rev. 2024; 44(1):6.

PMID: 39585533 DOI: 10.1007/s10555-024-10223-5.


Mesenchymal Stem Cell-Secreted Exosomes and Soluble Signals Regulate Breast Cancer Metastatic Dormancy: Current Progress and Future Outlook.

Dai B, Clark A, Wells A Int J Mol Sci. 2024; 25(13).

PMID: 39000239 PMC: 11241820. DOI: 10.3390/ijms25137133.


Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway.

Alanteet A, Attia H, Alfayez M, Mahmood A, Alsaleh K, Alsanea S Saudi Pharm J. 2024; 32(1):101923.

PMID: 38223522 PMC: 10784703. DOI: 10.1016/j.jsps.2023.101923.


Improving Autologous Fat Grafting in Regenerative Surgery through Stem Cell-Assisted Lipotransfer.

Debuc B, Gendron N, Cras A, Rancic J, Philippe A, Cetrulo Jr C Stem Cell Rev Rep. 2023; 19(6):1726-1754.

PMID: 37261667 DOI: 10.1007/s12015-023-10568-4.


An In Vitro Approach for Investigating the Safety of Lipotransfer after Breast-Conserving Therapy.

Promny T, Kutz C, Jost T, Distel L, Kadam S, Schmid R J Pers Med. 2022; 12(8).

PMID: 36013233 PMC: 9409821. DOI: 10.3390/jpm12081284.